National Research Corporation (NASDAQ:NRCIB) has earned an average broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation.

Brokerages have set a 12-month consensus price target of $44.00 for the company and are forecasting that the company will post $0.23 earnings per share for the current quarter, according to Zacks. Zacks has also given National Research Corporation an industry rank of 98 out of 265 based on the ratings given to its competitors.

Shares of National Research Corporation (NRCIB) traded down 3.22% on Wednesday, reaching $53.42. The company’s stock had a trading volume of 3,530 shares. National Research Corporation has a 12-month low of $32.57 and a 12-month high of $57.21. The company’s 50-day moving average is $53.52 and its 200 day moving average is $46.47. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of 58.83 and a beta of 0.07.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 4.49%. The ex-dividend date of this dividend is Thursday, September 28th. National Research Corporation’s dividend payout ratio is presently 461.55%.

ILLEGAL ACTIVITY WARNING: “National Research Corporation (NRCIB) Receives Consensus Rating of “Hold” from Brokerages” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/16/national-research-corporation-nrcib-receives-consensus-rating-of-hold-from-brokerages.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Isthmus Partners LLC boosted its stake in shares of National Research Corporation by 1.5% in the first quarter. Isthmus Partners LLC now owns 4,756 shares of the business services provider’s stock worth $187,000 after acquiring an additional 72 shares during the period. Rice Hall James & Associates LLC boosted its stake in National Research Corporation by 1.0% during the second quarter. Rice Hall James & Associates LLC now owns 10,102 shares of the business services provider’s stock valued at $480,000 after buying an additional 104 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in National Research Corporation by 0.5% during the first quarter. Dimensional Fund Advisors LP now owns 90,616 shares of the business services provider’s stock valued at $3,570,000 after buying an additional 457 shares during the last quarter. Willis Investment Counsel boosted its stake in National Research Corporation by 1.7% during the second quarter. Willis Investment Counsel now owns 29,042 shares of the business services provider’s stock valued at $1,379,000 after buying an additional 490 shares during the last quarter. Finally, WCM Investment Management CA boosted its stake in National Research Corporation by 1.1% during the second quarter. WCM Investment Management CA now owns 51,423 shares of the business services provider’s stock valued at $2,455,000 after buying an additional 560 shares during the last quarter. 2.60% of the stock is owned by hedge funds and other institutional investors.

National Research Corporation Company Profile

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Get a free copy of the Zacks research report on National Research Corporation (NRCIB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related stocks with our FREE daily email newsletter.